Screen Shot 2020-04-27 at 11.19.31.pngA total of 5700 patients were included (median age, 63 years]; 39.7% female. The most common comorbidities were hypertension (56.6%), obesity (41.7%), and diabetes (33.8%). At triage, 30.7%of patients were febrile, 17.3% had a respiratory rate greater than 24 breaths/minute, and 27.8%received supplemental oxygen. The rate of respiratory virus co-infection was 2.1%. Outcomes were assessed for 2634 patients who were discharged or had died at the study end point. During hospitalization, 14.2% patients were treated in the intensive care unit care, 12.2% received invasive mechanical ventilation, 3.2% were treated with kidney replacement therapy, and 21% died. Mortality for those requiring mechanical ventilation was 88.1%. The median postdischarge follow-up time was 4.4 days. A total of 2.2% patients were readmitted during the study period. The median time to readmission was 3 days for readmitted patients.

Art S. Richardson_2020_Charx of COVID NYC